ch.oddb.org
 
Medikamente | Services | Zulassungsi.
Fachinformation zu Aethoxysklerol®:Recordati AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
C05BB02 - PolidocanolATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C05 - Vasoprotectives
 

No DDDs are established in this group, since most of the drugs in this group are for topical use.

C05B - Antivaricose Therapy

This group comprises all products for treatment of varices, i.v. infusion induced thrombophlebitis etc.
Zinc bandages, see D09A - Medicated dressings.

C05BB - Sclerosing Agents for Local Injection
 
C05BB02 - Polidocanol
2025 ©ywesee GmbH
Hilfe | FAQ | Anmeldung | Kontakt | Home